. However, when the same conjugates were used to introduce exogenous genes into cotton rats via the intratracheal route, the transgene was transiently expressed at low levels ( 12).
Introduction
Genes of interest can be targeted specifically to respiratory epithelial cells in intact animals with high efficiency by exploiting the receptor-mediated endocytosis of the polymeric immunoglobulin receptor. A DNA carrier, consisting of the Fab portion of polyclonal antibodies raised against rat secretory component covalently linked to poly-L-lysine, was used to introduce plasmids containing different reporter genes into airway epithelial cells in vivo. We observed significant levels of luciferase enzyme activity in protein extracts from the liver and lung, achieving maximum values of 13,795+4,431 and 346,954±199,120 integrated light units (RLU) per milligram of protein extract, respectively. No luciferase activity was detected in spleen or heart, which do not express the receptor. Transfections using complexes consisting of an irrelevant plasmid (pCMV lacZ) bound to the bona fide carrier or the expression plasmid (pGEMluc) bound to a carrier based on an irrelevant Fab fragment resulted in background levels of luciferase activity in all tissues examined. Thus, only tissues that contain cells bearing the polymeric immunoglobulin receptor are transfected, and transfection cannot be attributed to the nonspecific uptake of an irrelevant carrier-DNA complex. Specific mRNA from the luciferase gene was also detected in the lungs of transfected animals. To determine which cells in the lung are transfected by this method, DNA complexes were prepared containing expression plasmids with genes encoding the bacterial 8-galactosidase or the human interleukin 2 receptor. Expression of these genes was localized to the surface epithelium of the airways and the submucosal glands, and not the bronchioles and alveoli. Receptor-mediated endocytosis can be used to introduce functional genes into the respiratory epithelium of rats, and may be a useful technique for gene therapy targeting the lung. (J. Clin. Invest. 1995 (1) , thus permitting flexibility not only in the selection of the transgene but also in the choice of promoter and enhancer elements. The delivery of exogenous DNA using receptor-mediated systems depends on the stability of the carrier-DNA complex, the presence and number of receptors on the surface of the targeted cell, the receptor-ligand affinity and interaction, and efficient internalization of the complex (2, 3) . Furthermore, the transferred genes must escape from endosomes (4, 5) and traffic to the target cell's nucleus. This strategy has been used to introduce reporter genes into cells in culture, and results in transient but high levels of expression from the transgene. However, receptor-mediated gene transfer systems have produced variable results in vivo. The transgene is expressed for a short time at low levels (6, 7) unless invasive manipulation of the animal, such as partial hepatectomy, is performed (8) (9) (10) . However, Perales and (1, 5) . However, when the same conjugates were used to introduce exogenous genes into cotton rats via the intratracheal route, the transgene was transiently expressed at low levels ( 12) .
We have demonstrated that in primary cultures of human tracheal epithelial cells, targeting the polymeric immunoglobulin receptor (pIgR)' can be used for the specific delivery of reporter genes to cells that bear the receptor (2). This receptor undergoes efficient internalization and is specifically adapted for the nondegradative transfer of large molecules. In addition, the cellular distribution of pIgR expression in the surface epithelium and serous cells of the submucosal glands conforms to that of the cystic fibrosis transmembrane conductance regulator in human airways (13, 14) . In this report, we show that tar-geting the pIgR in rats results in significant expression of the transgene in tissues that contain receptor-bearing cells, which was maximal 6 d after transfection.
Methods
Materials. DNA-modifying enzymes, nucleotides, and 5-Bromo-4-chloro-3-indolyl-,6-D-galactopyranoside were purchased from Boehringer Mannheim (Indianapolis, IN). GeneScreen Plus and [a 32p] dCTP were obtained from DuPont-New England Nuclear (Boston, MA). Protein A MAPS agarose columns were purchased from Bio Rad (Richmond, CA). Papain and poly-L-lysine were obtained from Sigma Chemical Co. (St. Louis, MO), and N-Succinimidyl-3-(2-pyridyldithio)proprionate was purchased from Pierce Chemical Co. (Rockford, IL). Promega (Madison, WI) assay reagents were used to measure luciferase activity. Reverse transcriptase and polymerase chain reaction reagents were obtained from Perkin Elmer Cetus (Norwalk, CT). The mouse monoclonal anti-interleukin 2 receptor antibody was obtained from Dako Corp. (Carpenteria, CA).
Production of carrier-DNA complexes that target the polymeric immunoglobulin receptor. Two features of this system are critical for the successful introduction of genes into the airway epithelial cells: (a) anti-secretory component (SC) Fab antibodies serve as the targeting ligand in this gene transfer system, which permits specific delivery of genes to cells that express pIgR; and (b) the condensation of the DNA by the anti-SC Fab-based carrier into highly compact complexes suitable for efficient uptake via an endocytic pathway.
Preparation of Fab antibody fragments. Polyclonal antisera were raised in rabbits against SC purified from rat bile (15) . The antibody recognizes purified SC, secretory IgA, and the pIgR, but not dimeric IgA. The antiserum was stored in l-ml aliquots at -20TC until the immunoglobulin G (IgG) was isolated. The antibody was isolated by Protein A MAPS agarose chromatography as described by the manufacturer. Fab fragments were prepared and isolated as described previously for the anti-human SC Fab-based carrier (2) (2) . The conditions necessary to ensure condensation of the DNA depend on a number of variables, including the size, sequence and physical state of the DNA, the chain length of the poly-L-lysine, and the nature of the ligand. The optimal concentration of sodium chloride required to effectively compact the plasmid is also dependent on these variables (11 ) .
DNA was condensed by the slow addition of the anti-SC Fab carrier in the presence of 400 mM sodium chloride and constant vortexing for 30 min at room temperature. After the addition of the carrier to the DNA, the sodium chloride concentration in the solution was adjusted by adding 3-t1t aliquots of 5 M NaCl. As the ionic strength of the solution was increased, the anti-SC Fab-polylysine-DNA complexes proceeded from an aggregated to a condensed state, and the turbidity of the mixture cleared ( 11) . The final volume of the solutions was 300-500 y1, and contained 300 ,/.g of plasmid DNA in 470-650 mM NaCl.
Different final concentrations of sodium chloride in different preparations of the complexes was primarily due to heterogeneity in size of the poly-L-lysine component of the carrier. Based on our previous experiments (11) , the optimal charge ratio of the DNA phosphate groups to lysine was approximately 1:0.7. The condensation process was monitored by circular dichroism spectroscopy and electron microscopy (11) .
The expression plasmid pGL2 (Promega) contained the SV40 viral promoter and enhancer ligated to the Photinus pyralis luciferase gene, and inserted into the Escherichia coli pUC19 vector. The plasmids pCMV lacZ (17) Detection of luciferase mRNA using the polymerase chain reaction.
The presence of mRNA transcripts from the luciferase gene in the lungs of rats was determined 6 and 12 d after transfection by treatment of total cellular RNA with Moloney Murine Leukemia Virus reverse transcriptase and amplification of the resultant cDNA by the polymerase chain reaction. Briefly, 1 jg of total rat liver RNA was added to a solution containing 500 nM of (dT)16 oligonucleotide primer and 500 nM of each deoxynucleotide triphosphate, and heated to 420C for 2 min.
Reverse transcriptase was added, the mixture was incubated for 30 min at 420C, and 1 j1 of the cDNA pool was amplified by the polymerase chain reaction, using primers within the chimeric luciferase gene described above. Because of the presence of an intron 66 base pairs in length, the sizes of the amplified sequences from plasmid DNA and cDNA generated from RNA after treatment with reverse transcriptase are different, which distinguished transferred DNA from mRNA transcribed from the transgene. The expected length of the amplified cDNA from the luciferase mRNA was 666 bp. As a control, rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA was also amplified using similar conditions with primer CCATGGAGAAGGCTGGGGC (GAPDH 5'), which corresponds to positions 371 to 389 in the GAPDH gene, and primer CAAAGTTGTCATGGATGACC (GAPDH 3'), an antisense primer which corresponds to positions 546 to 565. The expected size of the amplified cDNA generated from the rat GAPDH mRNA was 194 base pairs. The RNA isolated from lungs of transfected and nontransfected rats was evaluated. In addition, the same RNA samples not converted to cDNA by reverse transcriptase were used as polymerase chain reaction templates as controls to establish that contaminating plasmid DNA had not been amplified. The products were separated by agarose gel electrophoresis and their identity verified by Southern blot hybridization using a radiolabelled luciferase or glyceraldehyde-3-phosphate dehydrogenase DNA probes.
Cytochemical assay for fB-galactosidase activity. Individual cells expressing ,6-galactosidase in tissues were identified after incubation with 5-Bromo-4-chloro-3-indolyl-,j-galactopyranoside (X-gal). Briefly, the cells were fixed with a solution of 0.5% glutaraldehyde in PBS for 10 min, washed twice with PBS, pH 7.5, and then incubated with a solution containing 0.5% X-gal dissolved in N-N-dimethylformamide, 5 mM potassium ferricyanate, 5 mM potassium ferrocyanide, and 1 mM magnesium chloride in PBS (pH 7.4) for 4 h at 37°C. After incubation, the tissues were fixed in 2% para formaldehyde/0.5% glutaraldehyde in PBS overnight at 40C, paraffin embedded, and cut into 5-jIm sections.
The sections were counter-stained with nuclear fast red, and blue colored cells were identified by light microscopy. In addition, adjacent sections were stained with Alcian blue (pH 2.5)/periodic acid Schiff or hematoxylin/eosin using standard protocols (19) .
Immunohistochemical staining for the interleukin 2 receptor. The expression of the transgene in tissues transfected with the plasmid pCMVIL2r was determined by indirect immunofluorescence. Frozen sections (10 jm) of trachea were fixed with acetone for 10 min at -20°C and treated with 0.5% sodium borohydride in water for 10 min at 22°C to reduce autofluorescence. The sections were then incubated sequentially with a mouse monoclonal anti-interleukin 2 receptor antibody for 1 h at 370C, then fluorescein isothiocyanate-conjugated goat anti-mouse IgG for 1 h at 37°C. Both the primary and secondary antibodies were diluted 1:100 in PBS, and between each incubation the slides were washed three times for 5 min with PBS, pH 7.5. The stained tissue sections were examined by fluorescence microscopy using an inverted Zeiss epifluorescence microscope and emitted light was detected by a cooled CCD camera.
Assays for luciferase activity. Tissues were harvested from transfected and control rats after the animals were sacrificed and perfused in situ with cold PBS, pH 7.5, for 5 min. The tissues were homogenized in lysis buffer (Promega) and permitted to incubate at 220C for 10 min. These lysates were centrifuged for 5 min at 4°C, and the supernatants were analyzed for luciferase activity. The lysates were assayed for protein content using the Bradford method and the measured integrated light units (10 s interval) were standardized for total protein content (20) . All measurements were performed in triplicate and expressed as an average of the values.
Immunohistochemical staining of rat tracheasfor plgR. The expression of pIgR in rat tracheal epithelial cells was determined by indirect immunofluorescence. Tracheal sections were frozen then fixed with acetone at -20'C for 10 min, and incubated sequentially with rabbit antirat SC for 1 h at 370C, then rhodamine-conjugated goat anti-rabbit IgG for 1 h at 37°C. Both antibodies were diluted 1:100 in PBS, pH 7.5. Between each incubation, the slides were washed three times with PBS, pH 7.5. The stained tissues were examined by fluorescence microscopy as described above.
Statistical analysis. Data are expressed as means±standard error of the mean (SEM), and evaluated by a nonparametric analysis of variance using the Kruskall-Wallis test (21) .
Results
Construction of the anti-secretory component Fab antibodybased carrier-DNA complexes. An essential step in the assembly of a carrier-DNA complex capable of efficient gene transfer in animals is the condensation of the plasmid DNA to a size and shape suitable for uptake via an endocytic pathway. Perales and colleagues ( 11) described a procedure for condensation of individual DNA molecules into unimolecular complexes of defined structure by adjusting the charge neutralization of the DNA by the slow addition of ligand-polylysine conjugates in the presence of high concentrations of sodium chloride. This technique permits a change in the conformation of the DNA molecule allowing the flexible polymer to bend and become more compact. This condensation process is monitored by circular dichroism spectroscopy and by electron microscopy of the DNA complexes. As shown in the electron photomicrographs in Fig. 1 , complexes made using the anti-rat SC Fab-polylysine carrier are compact toroids approximately 25 nm in diameter.
Small circular structures measuring 1 nm in diameter were noted in preparations of both the complexes and the conjugate alone, and most likely represents the anti-SC Fab-polylysine carrier. In comparison, a carrier consisting of galactosylated polylysine condensed individual DNA molecules into toroid structures measuring 10-12 nm in diameter (11) .
In vivo transfection using the anti-secretory component Fab antibody-polylysine carrier. We tested the transfer of reporter genes into the airway epithelium in vivo by the systemic injection of a targeting complex consisting of the Fab portion of IgG directed against rat SC, the extracellular domain of pIgR, conjugated to poly-L-lysine, and noncovalently bound to reporter genes. The results of luciferase assays performed 6 d after infusion of the complexes in tissue homogenates extracted from liver, lungs, spleen, and heart are shown in Fig. 2 . In animals injected with the anti-rat SC Fab-polylysine carrier-DNA complex, we observed transgene expression in protein extracts from the liver and lungs, but not from the spleen and heart, tissues that do not express the pIgR (22) . Furthermore, animals treated with the complexes prepared with an irrelevant plasmid (pCMV lacZ) bound to the bona fide carrier, or the expression plasmid (pGL2) bound to a carrier prepared with an irrelevant Fab fragment had no significant luciferase activity in any tissue examined. Tissues from animals injected with a mixture of the individual, nonconjugated components of the complex (not conjugated) also did not have transgene expression (data not shown). Thus, only tissues that contain cells bearing pIgR are transfected by our procedure, and DNA uptake cannot be attributed to nonspecific introduction of an irrelevant Fab antibody-based complex.
The time course of luciferase expression is illustrated in Fig. 3 . The maximum levels of luciferase activity was detected in the liver 4 12 (Fig. 3) .
The transgene was detected in the lungs of animals 12 d after transfection by polymerase chain reaction amplification using primers specific for the luciferase gene (Fig. 4 a) . Amplification of DNA extracted from the lungs of nontransfected and mock-transfected rats did not demonstrate the transferred gene. Furthermore, the mRNA transcripts from the luciferase gene were detected in the lungs of rats after transfection by treating total cellular RNA with reverse transcriptase and amplifying the cDNA by the polymerase chain reaction, using oligonucleotide primers specific for the luciferase gene. All RNA samples were evaluated in the presence and absence of reverse transcriptase to further ensure that contamination with plasmid DNA had not occurred. As shown in Fig. 4 ity. An animal treated with complexes made using an irrelevant plasmid (pCMVIL2r) served as a control, and no blue-stained cells were detected in the tracheal epithelium or submucosal glands (Fig. 5 a) . As shown in Fig. 5 b, expression of the transgene in the trachea was limited generally to the cells lining the epithelial surface. Six different tracheal sections and a total of 2464 cells were examined, and an average of 17.7% of the tracheal epithelial cells stained blue. Expression ranged from 10.9 to 27.7% of the airway epithelial cells in different sections.
Although the staining appears to be localized to the apices of the tracheal epithelial cells at lower magnifications, higher magnification demonstrates blue staining throughout the cytoplasm conforming to the shape of the cell (Fig. 5 c) . Both ciliated and secretory (goblet) respiratory epithelial cells expressed ,/-galactosidase, and blue-stained cells were also identified in the submucosal glands (Fig. 5 d) . However, transfection efficiency of the submucosal glands was difficult to determine accurately because few glands were found in sections of the proximal trachea. No expression from the transgene was detected in the terminal or respiratory bronchioles, or in the alveolar pneumocytes (data not shown).
The expression of /3-galactosidase parallels the distribution of pIgR in the rat and human airway. As illustrated in Fig. 6 , the pIgR was detected in the surface epithelium and submucosal glands of rat trachea, but not in alveoli. Confirmatory studies using the human IL2r, a surface protein that has been used as a reporter in the transduction of respiratory epithelial cells in vitro (23) , as a reporter gene demonstrated that transgene expression was specifically localized in the airway epithelium. Immunofluorescence was specifically localized to the apical surface of numerous respiratory epithelial cells from the animal transfected with the plasmid pCMVIL2r (data not shown), which was absent from the airway epithelia of nontransfected rats or animals transfected with pCMV lacZ (data not shown). (300 IHg) complexed to the anti-rat SC Fab-based carrier was infused into the caudal vena cava of rats (Transfected, n = 4). 6 d after injection the animals were killed and protein extracts from the spleen, heart, liver, and lung were assayed for luciferase activity. Figure 3 . Duration of transgene expression after introduction into the livers and lungs of rats using the anti-rat SC Fab-polylysine carrier. In four separate experiments, 300 lsg of the plasmid pGL2 complexed to the anti-rat secretory component Fab antibody-carrier was infused into the caudal vena cava of rats. Animals were killed 2 (n = 3), 4 (n = 3), 6 (n = 4), 8 (n = 2), 12 (n = 3), and 18 (n = 2) d after injection, and cell lysates from the liver and lung were assayed for luciferase expression. Protein extracts obtained from the livers and lungs of three untreated rats were used as controls. (36) . Moreover, this system permits the delivery of functional genes from the circulation. This ability of the anti-SC Fab-based carrier to transfect only epithelial and submucosal gland cells in the airways may be an important advantage, since the approach from the blood may permit more uniform distribu- (37, 38) .
Several additional explanations for this difference in transgene expression are possible, including unequal levels of expression of the receptor, competition from the natural ligand, or the trafficking of the DNA-carrier complex in the particular cell. In rodents, pIgR expression, based on the production of SC, is significantly greater in the liver than lung (39) . Radiola- beled dIgA injected into the systemic circulation of rats is transported from blood to bile over 20 times more rapidly than it is transported into the airways (40 (41) . Since we have observed prolonged expression of transgenes in hepatocytes delivered using a galactosylated polylysine carrier (11), we believe that the compacted form of the plasmid contributes to the survival and the protracted expression of the transferred gene. This preparation of highly condensed DNA complexes using the anti-rat SC Fab-based carrier was different from that described in our previous work with the anti-human SC Fab-polylysine (2), and was patterned after the method of condensation we used for experiments to target the asialoglycoprotein receptor (11) , though the exact concentrations of sodium chloride were different from those used with galactosylated polylysine carrier. Complexes made using the anti-SC Fab carrier-DNA complex were larger than those containing galactose-terminal glycoprotein (11), as judged by electron microscopy, most likely due to the effects of the Fab fragment on the interaction of the polycation and DNA, but are still substantially smaller than other reported complexes (41) . The size of the complexes can be important because many endocytotic receptors discriminate against ligands of a determined size range in vivo (42, 43). We expect that the pIgR, however, can accommodate larger complexes than the asialoglycoprotein receptor. Indeed, the pIgR is adapted for the uptake of large, multimeric molecules, and immune complexes formed with its natural ligand can be efficiently internalized (44) .
The size and structure of the complexes may also be important for its stability in the blood, receptor-ligand interaction, . (46, 47 In summary, the pIgR seems to be a promising receptor to target to achieve transgene delivery and expression in vivo. The distribution of this receptor in airway epithelium and the serous cells of the submucosal glands may be especially useful for the correction of the genetic defect that results in cystic fibrosis (13) .
